When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CEMI - Chembio Diagnostics rises 8% after-hours after submitting EUA for COVID test
Chembio Diagnostics Inc.
Shares of Chembio Diagnostics (NASDAQ:CEMI) are up 8% in after-hours trading after announcing that it has submitted an Emergency Use Authorization to the FDA for its DPP SARS-CoV-2 Antigen test. The test is designed to provide results in 20 minutes and use a minimally invasive nasal swab. The test was developed with funding from the Biomedical Advanced Research and Development Authority ("BARDA"). Read about Chembio's recent Q3 2021 earnings results.